drugset / Trial / NCT00490854

A Study for Patients With Type 2 Diabetes Mellitus

NCT00490854

Phase 2/3 Completed 129 enrolled Eli Lilly and Company Alkermes, Inc. · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare the human insulin inhalation powder plus oral anti-hyperglycemic medication with injected insulin (neutral protamine hegedom insulin) plus oral anti-hyperglycemic medication on lowering the blood sugar level.

Timeline

Start
2007-07
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Other
Subject Neutral protamine hagedorn insulin Protein / enzyme biologic Other